Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02571998 · ClinicalTrials.gov registry record · Phase 2

A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris

A Phase 2 study of Acne Vulgaris, sponsored by Maruho Co..

Completed
Registry status
Phase 2
Development phase
320
Enrollment target
20
Study locations

NCT02571998 is a Phase 2 study of Acne Vulgaris that has completed, run by Maruho Co.. The registered enrollment target is 320 participants, above the 271-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (18% higher). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02571998, a Phase 2 study of Acne Vulgaris, has completed, sponsored by Maruho Co..

COMPLETED
Registry status
Phase 2
Development phase
320 participants
Enrollment target
20
Study locations

Study Summary

The primary objective of this study is to evaluate the safety and efficacy of Omiganan (CLS001) topical gel compared to vehicle topical gel applied once daily for 12 weeks in female subjects with moderate to severe inflammatory acne vulgaris.

Conditions Studied

Acne Vulgaris

Interventions

  • DRUG Vehicle Topical Gel
  • DRUG Omiganan (CLS001) Topical Gel

Study Locations (20)

Florida

  • - Boca Raton
  • - Boynton Beach
  • - Miami
  • - Pinellas Park
  • - Sanford
  • - Tampa

California

  • - Santa Ana
  • - Santa Monica

New York

  • - New York
  • - Stony Brook

Alabama

  • - Mobile

Arizona

  • - Phoenix

Colorado

  • - Denver

Massachusetts

  • - Beverly

Michigan

  • - Fort Gratiot

Trial Details

FieldValue
Enrollment Target 320 participants
Start Date 2015-10
Est. Completion 2016-08
Phase Phase 2

Sponsor

Maruho Co.

10 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02571998

The ClinicalTrials.gov registry entry for NCT02571998 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 271-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (18% higher). The listed sponsor is Maruho Co., which has 10 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acne Vulgaris appearing as the primary indexed condition, and to 2 interventions - of which Vehicle Topical Gel is the first listed.

NCT02571998 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Florida, California, New York.

Frequently Asked Questions

What is clinical trial NCT02571998 about?

NCT02571998 is a clinical study titled "A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris". The primary objective of this study is to evaluate the safety and efficacy of Omiganan (CLS001) topical gel compared to vehicle topical gel applied once daily for 12 weeks in female subjects with moderate to severe inflammatory acne vulgaris.

What is the current status of trial NCT02571998?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 320 participants. The study started on 2015-10. Estimated completion is 2016-08.

What conditions does trial NCT02571998 study?

This clinical trial studies the following conditions: Acne Vulgaris.

What interventions are being tested in trial NCT02571998?

The interventions under investigation include: Vehicle Topical Gel (DRUG), Omiganan (CLS001) Topical Gel (DRUG).

Who is sponsoring clinical trial NCT02571998?

This trial is sponsored by Maruho Co., which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02571998 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Acne Vulgaris

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Acne Vulgaris

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.